{"product_id":"argatroban-in-sodium-chloride-injection-50-mg50-ml-rx","title":"Argatroban in Sodium Chloride Injection 50 mg\/50 mL (RX)","description":"\u003cp\u003eArgatroban in Sodium Chloride Injection 50 mg\/50 mL is a medication used to prevent blood clots in patients who have medical conditions such as heparin-induced thrombocytopenia or HIT. It is a sterile solution containing argatroban, a direct thrombin inhibitor, and sodium chloride as a diluent. The 50 mg\/50 mL strength means that each vial or bag contains 50 mg of argatroban in 50 mL of sodium chloride solution. It is administered intravenously (IV) and prescribed by a doctor or healthcare provider for therapeutic purposes.\u003c\/p\u003e\n\u003ch3\u003eFast, Reliable Anticoagulation: Argatroban in Sodium Chloride Injection 50 mg\/50 mL by Eugia US\u003c\/h3\u003e\n\u003cp\u003eFor healthcare providers demanding precision and safety in anticoagulation therapy, \u003cstrong\u003eArgatroban in Sodium Chloride Injection 50 mg\/50 mL\u003c\/strong\u003e by Eugia US (NDC: 55150-0241-01) delivers effective, FDA-approved direct thrombin inhibition in a convenient, ready-to-use formulation. This hospital-standard solution is crucial in managing patients with heparin-induced thrombocytopenia (HIT) and during procedures requiring acute anticoagulation.\u003c\/p\u003e\n\u003ch3\u003eUses\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeparin-Induced Thrombocytopenia (HIT):\u003c\/strong\u003e Indicated for both the prophylaxis and treatment of thrombosis in adult patients with HIT.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePercutaneous Coronary Intervention (PCI):\u003c\/strong\u003e Provides anticoagulation in patients with or at risk for HIT undergoing PCI.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlternative Anticoagulation:\u003c\/strong\u003e Used when heparin or low molecular weight heparins are contraindicated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBenefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use Injection:\u003c\/strong\u003e Pre-mixed formulation in 0.9% sodium chloride ensures convenience, sterility, and dosing accuracy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Onset \u0026amp; Reliable Control:\u003c\/strong\u003e Begins anticoagulation effects quickly, ideal for acute and critical care settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo Cross-reactivity with Heparin:\u003c\/strong\u003e Safe for use in patients with heparin allergies or HIT.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufactured by Eugia US:\u003c\/strong\u003e Trusted pharmaceutical quality and strict adherence to safety standards.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimizes Medication Errors:\u003c\/strong\u003e Reduces compounding time and contamination risks associated with manual preparation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cstrong\u003eFeature\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eDetail\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eArgatroban in Sodium Chloride Injection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStrength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e50 mg\/50 mL (1 mg\/mL)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePremixed IV solution in 0.9% sodium chloride\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSingle-dose 50 mL vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNDC\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e55150-0241-01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRoute\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIntravenous (IV) infusion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20-25°C (68-77°F), do not freeze\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEugia US\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrescription\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRx Only\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eDirections\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eFor hospital and professional healthcare use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe solution is premixed and ready for IV administration; do not dilute further.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAdminister as a continuous IV infusion using a calibrated infusion device.\u003c\/li\u003e\n\u003cli\u003eInitiate therapy at the recommended initial rate (typically 2 mcg\/kg\/min), adjust according to activated partial thromboplastin time (aPTT) or per physician protocol.\u003c\/li\u003e\n\u003cli\u003eFor PCI, follow specific dosing and monitoring instructions as outlined in product literature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eRegularly monitor aPTT or ACT to ensure therapeutic levels and adjust dose as needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUse Immediately:\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDiscard unused portion after single patient use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eAlways follow institutional protocols and the prescribing healthcare provider’s instructions for dosing and adjustments.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eSide Effects\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBleeding or hematoma at the infusion site\u003c\/li\u003e\n\u003cli\u003eHypotension\u003c\/li\u003e\n\u003cli\u003eNausea or vomiting\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003cli\u003eDyspnea\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious\/Rare Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere bleeding (gastrointestinal, intracranial, or other sites)\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (rash, itching, anaphylaxis)\u003c\/li\u003e\n\u003cli\u003eLiver enzyme elevation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSeek immediate medical attention for signs of excessive bleeding, severe dizziness, shortness of breath, or allergic reactions.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eWarnings\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRisk of Bleeding:\u003c\/strong\u003e Argatroban increases the risk of bleeding in all settings; monitor closely and adjust dosage as required.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic Impairment:\u003c\/strong\u003e Reduce dose in patients with liver dysfunction and monitor more frequently due to increased exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug Interactions:\u003c\/strong\u003e Caution with concomitant use of other anticoagulants, antiplatelet agents, or thrombolytics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot for IM or SC Use:\u003c\/strong\u003e For intravenous administration only.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy\/Breastfeeding:\u003c\/strong\u003e Use only if clearly needed and prescribed by a physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePediatric Use:\u003c\/strong\u003e Safety and efficacy not established in children.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Argatroban in Sodium Chloride Injection by Eugia US?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eArgatroban in Sodium Chloride Injection 50 mg\/50 mL\u003c\/strong\u003e by Eugia US (NDC: 55150-0241-01) meets clinical demands for rapid, precise, and safe anticoagulation. The ready-to-use, pre-mixed vial minimizes preparation errors and maximizes efficiency in acute and emergency care, making it the preferred choice among hospitals and clinicians for treating HIT and supporting PCI procedures.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eOrder Argatroban in Sodium Chloride Injection 50 mg\/50 mL by Eugia US today for dependable, immediate anticoagulant therapy.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Eugia US","offers":[{"title":"Default Title","offer_id":68121784058224,"sku":"oia1793473832090","price":129.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1018\/3000\/1008\/files\/argatroban-in-sodium-chloride-injection-50-mg50-ml-rx_1.jpg?v=1793473840","url":"https:\/\/faymulch.shop\/products\/argatroban-in-sodium-chloride-injection-50-mg50-ml-rx","provider":"My Store","version":"1.0","type":"link"}